Focus on Minimizing Toxicity and Biomarker Identification by 2025

bir ses eklendi Health

2025-12-17 07:09:33 -

By 2025, Immunotherapy Progress will be focused on two key areas: minimizing the unique spectrum of side effects associated with immune-targeted drugs and identifying reliable biomarkers that predict response. Unlike the adverse events from kinase inhibitors, immune-related side effects require distinct management protocols. Furthermore, researchers are urgently seeking a predictive biomarker...

0 Yorumlar 0 hisse senetleri 3 Views 0 önizleme